Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 208 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Tziomalos, Konstantinos  [Clear All Filters]
Journal Article
Makri, E., & Tziomalos K. (2017).  Prevalence, etiology and management of non-alcoholic fatty liver disease in patients with polycystic ovary syndrome.. Minerva Endocrinol. 42(2), 122-131.
Panidis, D., Macut D., Tziomalos K., Papadakis E., Mikhailidis K., Kandaraki E. A., et al. (2013).  Prevalence of metabolic syndrome in women with polycystic ovary syndrome.. Clin Endocrinol (Oxf). 78(4), 586-92.
Tziomalos, K., Kirkineska L., Baltatzi M., Efthymiou E., Psianou K., Papastergiou N., et al. (2013).  Prevalence of resistant hypertension in 1810 patients followed up in a specialized outpatient clinic and its association with the metabolic syndrome.. Blood Press. 22(5), 307-11.
Lazaridou, S., Dinas K., & Tziomalos K. (2017).  Prevalence, pathogenesis and management of prediabetes and type 2 diabetes mellitus in patients with polycystic ovary syndrome.. Hormones (Athens). 16(4), 373-380.
Athyros, V. G., Katsiki N., Tziomalos K., & Karagiannis A. (2011).  Preventing Cardio-renal Syndrome Rather than Treating It: Could Statins Play A Role?. Open Cardiovasc Med J. 5, 226-30.
Athyros, V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2008).  Preventing macrovascular complications of diabetes: where do we stand with glycemic control?. Expert Opin Investig Drugs. 17(12), 1777-9.
Athyros, V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2010).  Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes?. Curr Pharm Des. 16(34), 3939-847.
Kakafika, A. I., Athyros V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2008).  Primary and secondary coronary heart disease prevention using statins: is targeting Adam or Eve equally effective?. Expert Opin Pharmacother. 9(9), 1437-40.
Tziomalos, K., Bouziana S. D., Spanou M., Kostaki S., Papadopoulou M., Giampatzis V., et al. (2015).  Prior treatment with dipeptidyl peptidase 4 inhibitors is associated with better functional outcome and lower in-hospital mortality in patients with type 2 diabetes mellitus admitted with acute ischaemic stroke.. Diab Vasc Dis Res. 12(6), 463-6.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Kostaki S., Papadopoulou M., et al. (2017).  Prognostic significance of major lipids in patients with acute ischemic stroke.. Metab Brain Dis. 32(2), 395-400.
Hatzitolios, A. I., Spanou M., Dambali R., Vraka K., Doumarapis E., Petratos K., et al. (2014).  Public awareness of stroke symptoms and risk factors and response to acute stroke in Northern Greece.. Int J Stroke. 9(4), E15.
Pagourelias, E. D., Gossios T. D., Tziomalos K., Karagiannis A., Geleris P., & Athyros V. G. (2011).  Residual cardiac risk reduction beyond lipid lowering.. Hellenic J Cardiol. 52(3), 197-203.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Papadopoulou M., Kostaki S., et al. (2015).  Response to "Brachial Systolic Blood Pressure Fails to Predict Short-Term Outcome in Patients With Acute Ischemic Stroke: What About Central Systolic Pressure?".. Am J Hypertens. 28(9), 1181.
Bouziana, S., Tziomalos K., Goulas A., & Ηatzitolios A. Ι. (2016).  The role of adipokines in ischemic stroke risk stratification.. Int J Stroke. 11(4), 389-98.
Tziomalos, K., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2010).  The role of ankle brachial index and carotid intima-media thickness in vascular risk stratification.. Curr Opin Cardiol. 25(4), 394-8.
Chatzis, P., Tziomalos K., Pratilas G. C., Makris V., Sotiriadis A., & Dinas K. (2018).  The Role of Antiobesity Agents in the Management of Polycystic Ovary Syndrome.. Folia Med (Plovdiv). 60(4), 512-520.
Ioannidou, E., Tseriotis V-S., & Tziomalos K. (2017).  Role of lipid-lowering agents in the management of diabetic retinopathy.. World J Diabetes. 8(1), 1-6.
Panidis, D., Tziomalos K., Papadakis E., Chatzis P., Kandaraki E. A., Tsourdi E. A., et al. (2014).  The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.. Clin Endocrinol (Oxf). 80(3), 432-8.
Tziomalos, K. (2017).  The Role of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in the Management of Dyslipidemia.. Curr Pharm Des. 23(10), 1495-1499.
Karagiannis, A., Mikhailidis D. P., Athyros V. G., Kakafika A. I., Tziomalos K., Liberopoulos E. N., et al. (2007).  The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?. Expert Opin Ther Targets. 11(2), 191-205.
Tziomalos, K., Kakafika A. I., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2009).  The role of statins for the primary and secondary prevention of coronary heart disease in women.. Curr Pharm Des. 15(10), 1054-62.
Tziomalos, K., & Hare J. M. (2009).  Role of xanthine oxidoreductase in cardiac nitroso-redox imbalance.. Front Biosci (Landmark Ed). 14, 237-62.
Athyros, V. G., Tziomalos K., Gossios T. D., Griva T., Anagnostis P., Kargiotis K., et al. (2010).  Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis.. Lancet. 376(9756), 1916-22.
Athyros, V. G., Giouleme O., Ganotakis E. S., Elisaf M., Tziomalos K., Vassiliadis T., et al. (2011).  Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study.. Arch Med Sci. 7(5), 796-805.
Karagiannis, A., Tziomalos K., Mikhailidis D. P., Semertzidis P., Kountana E., Kakafika A. I., et al. (2010).  Seasonal variation in the occurrence of stroke in Northern Greece: a 10 year study in 8204 patients.. Neurol Res. 32(3), 326-31.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.